Cineverse (NASDAQ:CNVS) Azioni

Cineverse

Cineverse Corp is a main streaming technology and entertainment company. It operates portfolios of owned and operated streaming channels, all powered by its, proprietary technology platform. Cineverse features enthusiast brands for subscription video on demand (SVOD), advertising-based video on demand (AVOD), and free, ad-supported streaming television (FAST) channels. The company earns fees for the distribution of content in the home entertainment markets via several distribution channels, including digital, video-on-demand, and physical goods (e.g., DVDs and Blu-ray Discs) (Base Distribution).

Cineverse Corp

The Progressive Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PGR#NYSE">PGR</a>) today reported the following results for the month and quarter ended March&nbsp;31, 2025:
<figure class="table"> 
<table>
<tbody>
<tr>
<td colspan="10">March</td>
<td colspan="10">Quarter</td>
</tr>
<tr>
<td>(millions, except per share amounts and ratios; unaudited)</td>
<td>2025</td>
<td>2024</td>
<td colspan="3">Change</td>
<td>2025</td>
<td>2024</td>
<td colspan="3">Change</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
</tr>
<tr>
<td>Net premiums written</td>
<td>$</td>
<td>9,041</td>
<td>$</td>
<td>7,746</td>
<td>17</td>
<td>%</td>
<td>$</td>
<td>22,206</td>
<td>$</td>
<td>18,962</td>
<td>17</td>
<td>%</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
</tr>
<tr>
<td>Net premiums earned</td>
<td>$</td>
<td>6,787</td>
<td>$</td>
<td>5,634</td>
<td>20</td>
<td>%</td>
<td>$</td>
<td>19,409</td>
<td>$</td>
<td>16,149</td>
<td>20</td>
<td>%</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
</tr>
<tr>
<td>Net income</td>
<td>$</td>
<td>522</td>
<td>$</td>
<td>893</td>
<td>(42</td>
<td>)</td>
<td>%</td>
<td>$</td>
<td>2,567</td>
<td>$</td>
<td>2,331</td>
<td>10</td>
<td>%</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
</tr>
<tr>
<td>Per share available to common shareholders</td>
<td>$</td>
<td>0.89</td>
<td>$</td>
<td>1.52</td>
<td>(42</td>
<td>)</td>
<td>%</td>
<td>$</td>
<td>4.37</td>
<td>$</td>
<td>3.94</td>
<td>11</td>
<td>%</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
</tr>
<tr>
<td>Total pretax net realized gains (losses) on securities</td>
<td>$</td>
<td>(211</td>
<td>)</td>
<td>$</td>
<td>59</td>
<td>(458</td>
<td>)</td>
<td>%</td>
<td>$</td>
<td>(212</td>
<td>)</td>
<td>$</td>
<td>156</td>
<td>(236</td>
<td>)</td>
<td>%</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
</tr>
<tr>
<td>Combined ratio</td>
<td>90.9</td>
<td>84.3</td>
<td>6.6</td>
<td>pts.</td>
<td>86.0</td>
<td>86.1</td>
<td>(0.1</td>
<td>)</td>
<td>pts.</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
</tr>
<tr>
<td>Average diluted equivalent common shares</td>
<td>587.7</td>
<td>587.4</td>
<td>0</td>
<td>%</td>
<td>587.7</td>
<td>587.3</td>
<td>0</td>
<td>%</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
</tr>
</tbody>
</table>
</figure>

Earnings

News

Progressive March 2025 EPS $0.89 Down From $1.52 YoY; Net Premiums Written $9.041B, Up 17% YoY

Keybanc analyst Jason Celino maintains Autodesk (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADSK#NASDAQ">ADSK</a>) with a Overweight and lowers the price target from $335 to $323.

Price Target

Analyst Ratings

ADSK

Keybanc Maintains Overweight on Autodesk, Lowers Price Target to $323

‘Grandma friendly' DeFAI could bring blockchain finance to the masses.
In tech, new solutions can bring new problems. If a groundbreaking innovation is hard to use, more innovation will be needed to fix it.&nbsp;
That's where decentralized finance (DeFi) finds itself: ready to transform financial services but held back by jargon and fiddly processes that make it hard for newcomers to grasp.
Enter DeFAI, a mashup with agentic AI. This latest twist in the blockchain saga has the potential to cast-off DeFi's process-heavy chains and open it up to a wider audience.
Just tell a chatbot how to execute certain on-chain actions and it hands everything over to an AI agent, automating an often tricky and time-consuming series of technical steps. Anyone who's ever tried a new DeFi protocol for the first time will appreciate the potential benefits.
The current crop of DeFAI contenders wants to make handling crypto holdings easier for retail traders. Can they live up to the hype?
<h1 class="wp-block-heading">At a glance</h1>
<ul>
<li>Complexity, jargon, and an abundance of scams can be off-putting for DeFi newcomers</li>
<li>DeFAI – DeFi's integration with agentic AI –&nbsp;aims to change that. It allows users to run multi-step actions automatically using verbal commands</li>
<li>DeFAI can also strengthen security by minimizing input errors for common things like crypto wallet addresses</li>
<li>It could give retail traders more power to act on real-time market insights</li>
</ul>
<h1 class="wp-block-heading">The dawn of frictionless DeFi</h1>
It's hard to overstate DeFi's impact on financial services. Instant loans, peer-to-peer trading, permissionless transactions, and straightforward forex exposure through platforms like Uniswap (UNI) and Aave (AAVE) have changed forever how money and markets intersect.
But — and it&#8217;s a big but— using DeFi can be painful. Even technically accomplished traders balk at the manual and glitchy onboarding processes behind wallet setup, managing gas fees, staking, and completing cross-chain transactions.
DeFAI deploys AI agents to do the tedious stuff, arguably removing another roadblock to adoption. According to crypto researcher <a href="https://x.com/Defi0xJeff">0xJeff</a>, harnessing AI in this way could be transformational: "Why spend hours digging for alpha, manually executing trades, and trying to optimize your portfolio when you could have an agent do it for you?
"Autonomous trading agents are taking the idea of trading bots to the next level, transforming them into dynamic companions that adapt, learn, and make smarter decisions over time."
<h1 class="wp-block-heading">DeFAI applications in action</h1>
DeFAI solutions are being created that enable users to interact with DeFi protocols verbally via natural language processing (NLP). For example, placing a trade order or launching a new meme coin can be executed by simply chatting with an AI agent, e.g. giving it a vocal prompt.
One example is <a href="https://griffain.com/">Griffain</a>. It allows users to automate common on-chain tasks like buying and selling cryptocurrencies, creating tokens, and following airdrops.
AI agents can also source information in real-time and execute commands automatically based on what they learn, allowing crypto traders to act faster and potentially gain a market advantage.
<a href="https://heyanon.ai/welcome">HeyAnon</a> applies the principle to social media. Users can apply its decentralized application (dApp) to collect and analyze data from various sources, such as X (formerly Twitter), Telegram, GitHub, and Discord. Based on pre-set conditions, it then executes DeFi interactions such as token swaps, staking, lending, and bridging.
<h1 class="wp-block-heading">The top DeFAI projects by market cap</h1>
<h2 class="wp-block-heading">1. PAAL AI (PAAL)</h2>
PAAL AI enables users to build and deploy AI applications across various platforms such as Telegram, Discord, WhatsApp, and Slack. AI agents currently on<a href="https://www.paal.ai/"> PAAL AI </a>include workflow management programs, autonomous trading solutions, meme-creating tools, and more.
The PAAL token exists on the Ethereum (ETH) blockchain.
<h2 class="wp-block-heading">2. aixbt by Virtuals (AIXBT)</h2>
<a href="https://app.virtuals.io/virtuals/1199">Aixbt</a> is the most valuable AI agent on Virtuals, an on-chain protocol that allows developers to create AI agents and co-own them with other users via crypto tokens. A token is minted whenever a new AI agent is created, which crypto users can buy to gain co-ownership and access.
Aixbt agents act as an analytics tool, tracking crypto-related discussions on X to detect market trends.
<h2 class="wp-block-heading">3. ChainGPT (CGPT)</h2>
ChainGPT is a DeFAI token <a href="https://www.chaingpt.org/">operating </a>on the Binance Smart Chain and Ethereum networks. Users gain access to a suite of AI tools and applications including automated AI trading, blockchain analytics, and, smart contract creation.
The project aims to enhance the Web3 experience for retail users and startups. It uses a deflationary model with a burning mechanism to cap the overall supply at any given time.
<h1 class="wp-block-heading">Takeaway</h1>
In crypto, complexity is often the mother of invention. As of mid-January, DeFAI&#8217;s combined market cap surged by more than 350% in seven days, making it one of the most sought-after crypto investments in Q1.
Prices of the major DeFAI tokens have dropped in recent weeks, reflecting wider crypto market volatility and perhaps a wait-and-see attitude from investors.
Market watchers recognize DeFAI's potential to solve issues related to crypto user experience. How quickly users will flock to these solutions remains to be seen.

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Opinion

Markets

Trading Ideas

How Crypto Traders Can Benefit From DeFi's Fusion With AI?

Canaccord Genuity analyst George Gianarikas maintains Fluence Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLNC#NASDAQ">FLNC</a>) with a Buy and lowers the price target from $14 to $10.

FLNC

Canaccord Genuity Maintains Buy on Fluence Energy, Lowers Price Target to $10

Keybanc analyst Sangita Jain maintains AECOM (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACM#NYSE">ACM</a>) with a Overweight and lowers the price target from $121 to $109.

Keybanc Maintains Overweight on AECOM, Lowers Price Target to $109

B of A Securities analyst Vivek Arya maintains Marvell Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRVL#NASDAQ">MRVL</a>) with a Buy and lowers the price target from $120 to $72.

MRVL

B of A Securities Maintains Buy on Marvell Tech, Lowers Price Target to $72

Keybanc analyst Scott Schoenhaus maintains Absci (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABSI#NASDAQ">ABSI</a>) with a Overweight and raises the price target from $5 to $9.

ABSI

Keybanc Maintains Overweight on Absci, Raises Price Target to $9

Keybanc analyst Scott Schoenhaus maintains AbCellera Biologics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABCL#NASDAQ">ABCL</a>) with a Overweight and raises the price target from $4 to $5.

ABCL

Keybanc Maintains Overweight on AbCellera Biologics, Raises Price Target to $5

B of A Securities analyst Vivek Arya maintains ARM Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARM#NASDAQ">ARM</a>) with a Buy and lowers the price target from $180 to $144.

B of A Securities Maintains Buy on ARM Holdings, Lowers Price Target to $144

Prospective study to evaluate diagnostic performance and generate real-world data for the Mitomic&#xAE; Endometriosis Test, a potential non-invasive approach to surgical diagnosis for endometriosisAditxt, Inc.
Prospective study to evaluate diagnostic performance and generate real-world data for the Mitomic&#xAE; Endometriosis Test, a potential non-invasive approach to surgical diagnosis for endometriosis
Aditxt, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADTX#NASDAQ">ADTX</a>) ("Aditxt" or the "Company"), a social innovation platform accelerating promising health innovations, today announced that its subsidiary, Pearsanta, Inc. ("Pearsanta"), has received Institutional Review Board (IRB) approval from WCG Clinical to initiate a prospective clinical study evaluating the Mitomic&#xAE; Endometriosis Test (MET), a novel blood-based diagnostic designed to aid in the early detection of endometriosis.
The study, "Mitochondrial DNA Deletions in Plasma as a Diagnostic Aid for Females Presenting with Symptoms of Endometriosis," is designed to evaluate the clinical performance of MET compared to laparoscopic diagnosis, which is currently the gold standard for confirming endometriosis. Patient enrollment is expected to begin in May 2025. The prospective study will enroll up to 1,000 participants who are referred for diagnostic laparoscopy. Each participant will complete a symptom questionnaire and provide a pre-operative blood sample.
"IRB approval is a major milestone in our path to validate a diagnostic tool that we believe addresses a critical gap in women's health," said Chris Mitton, President of Pearsanta. "This study will generate real-world data on the clinical performance of MET in a pre-surgical population, helping us evaluate its accuracy across symptom profiles and disease subtypes. By targeting mitochondrial DNA deletions, MET is designed as a non-invasive alternative to current surgical diagnostic approaches, potentially bringing us closer to delivering earlier, more accessible detection for patients affected by endometriosis."
Study objectives include:
<ul>
<li>Evaluating the sensitivity and specificity of the Mitomic&#xAE; Endometriosis Test in detecting endometriosis compared to laparoscopic diagnosis</li>
<li>Assessing test performance across various disease subtypes to understand its utility in different clinical presentations</li>
<li>Exploring correlations between MET results, symptom profiles and demographic variables to assess the feasibility of personalized diagnostic insights</li>
<li>Establishing a biobank of clinical samples to enable future research, biomarker discovery and product development initiatives</li>
</ul>
"Endometriosis is an example of how early disease detection represents one of the most significant gaps in healthcare, with millions affected," said Amro Albanna, CEO of Aditxt. "This approval reflects Aditxt's commitment to addressing some of the most pressing health challenges through our subsidiaries and their programs."
Endometriosis affects an estimated 1 in 10 women globally, yet diagnosis can take 7 to 10 years on average due to the invasive nature of laparoscopy and lack of accurate, non-invasive tests. This diagnostic delay can lead to chronic pain, infertility and irreversible organ damage. Pearsanta's MET leverages its proprietary Mitomic&#xAE; Technology, which utilizes mitochondrial DNA (mtDNA) biomarkers to detect molecular signatures associated with disease, potentially enabling earlier detection through a simple blood draw.
The study is registered on ClinicalTrials.gov under identifier NCT06907550. Results from this clinical trial are intended to support the launch of MET as a Laboratory Developed Test (LDT) within Pearsanta's CLIA/CAP-certified laboratory in Richmond, Virginia.

ADTX

Aditxt's Pearsanta Receives IRB Approval From WCG Clinical To Initiate Prospective Clinical Study Evaluating Mitomic Endometriosis Test; Plans To Begin Patient Enrollment In May 2025

Redburn Atlantic analyst Oliver Holmes upgrades Union Pacific (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNP#NYSE">UNP</a>) from Neutral to Buy and announces $259 price target.

Upgrades

Redburn Atlantic Upgrades Union Pacific to Buy, Announces $259 Price Target

Community Trust Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTBI#NASDAQ">CTBI</a>) reported quarterly earnings of $1.22 per share which beat the analyst consensus estimate of $1.19 by 2.52 percent. This is a 17.31 percent increase over earnings of $1.04 per share from the same period last year.

CTBI

Community Trust Bancorp Q1 EPS $1.22 Beats $1.19 Estimate

Barrington Research analyst Vincent Colicchio maintains TD Synnex (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNX#NYSE">SNX</a>) with a Outperform and maintains $156 price target.

Barrington Research Maintains Outperform on TD Synnex, Maintains $156 Price Target

VALE S.A. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VALE#NYSE">VALE</a>) reported the first-quarter FY25 <a target="_blank" href="https://www.benzinga.com/topic/mining" rel="noreferrer noopener">production and sales performance</a> on Tuesday.
The company clocked iron ore production of 67.7 million tonnes (Mt), which was down 4.5% year over year (Y/Y), with production in the Northern System constrained by heavy rainfall.
Pellet production declined 15% Y/Y to 7.2 Mt primarily due to reduced availability of pellet feed in the quarter.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/02/43795425/rio-tinto-vs-vale-a-mining-showdown-ahead-of-q4-earnings" rel="noreferrer noopener">Rio Tinto Vs. Vale: Both Mining Stocks Show Bullish Technical Signals Ahead Of Q4 Earnings</a>
In the first quarter, Vale's iron ore sales increased 3.6% Y/Y to 66.1 million tonnes, aided by the sale of advanced inventories built-up in previous quarters.
The average realized price for iron ore fines was $90.8 per tonne (-9.8% Y/Y), primarily due to lower premium levels.
Similarly, the average pellet price declined 18.1% year over year to $140.8 per tonne, reflecting weaker contractual premiums during the quarter.
Meanwhile, Iron ore sales increased 4% year over year to 66.1 Mt, driven by an agile supply chain and strategic use of inventories.
Also, Copper production rose 11% Y/Y to 90.9 kt, with a strong performance from Salobo, Sossego, and Voisey's Bay thanks to the Salobo 3 and Voisey's Bay underground expansions.
Additionally, Nickel production surged 11% year over year to 43.9 kt, led by increased production at Onça Puma and solid results from Canadian operations, further enhanced by VBME's progress.
In February, Vale reported fourth-quarter net operating revenue decline of 22% Y/Y to $10.124 billion, beating&nbsp;the&nbsp;<a target="_blank" href="https://www.benzinga.com/25/02/43858670/vale-q4-lower-iron-ore-prices-weigh-on-earnings-approves-198-billion-in-dividends-interest-on-capital-renewed-buyback-program" rel="noreferrer noopener">consensus of $10.117 billion</a>.
Investors can gain exposure to the stock via VanEck Steel ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLX#NYSE">SLX</a>) and iShares Latin America 40 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ILF#NYSE">ILF</a>).
Price Action: VALE shares are up 0.22% at $9.15 premarket at the last check Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/03/44243837/iron-ore-production-to-accelerate-until-2030-study-says" target="_blank" rel="noreferrer noopener">Iron Ore Production To Accelerate Until 2030, Study Says</a></li>
</ul>
Photo by SERGIO V S RANGEL via Shutterstock

Equities

Large Cap

Commodities

VALE

Vale Q1 Iron Ore Output Falls 4.5% Amid Heavy Rains, Copper And Nickel Output Gain

Stephens &amp; Co. analyst Matt Olney maintains Hancock Whitney (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HWC#NASDAQ">HWC</a>) with a Overweight and lowers the price target from $73 to $69.

Stephens & Co. Maintains Overweight on Hancock Whitney, Lowers Price Target to $69

Guidance

XTNT

Xtant Medical Announces Completion Of Secondary Private Sale Of 73.1M Shares By Funds Affiliated With OrbiMed Advisors; Co. Also Says Expects Prelim. Q1 Revenue $32.8M-$33.1M, Representing 18-19% Growth YoY Driven By Orthobiologics And Licensing Revenue

Amid the staggering rally in the Gold prices, the gold fund net inflows have hit a record of $80 billion year-to-date, doubling over its previous record high in 2020, according to the BofA Global Investment Strategy report.
What Happened: A BofA Research graph shared by the Kobeissi Letter on X highlights how the investors have been pouring money into gold at a record pace amid the ongoing market uncertainty.
The Gold Spot US Dollar price has rallied 25.95% from $2,623.81 on Dec. 31, 2024, to $3,304.80 per ounce as of today. Its record high stood at $3,318 per ounce as of the publication of this article.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">BREAKING: Gold fund net inflows have hit a record $80 BILLION year-to-date. This is 2 TIMES more than the previous high set in the full year 2020. Investors are pouring money into gold at a record pace as the market uncertainty has skyrocketed. As a result, gold prices have… <a href="https://t.co/GyD3Srw6hu">pic.twitter.com/GyD3Srw6hu</a>
&mdash; The Kobeissi Letter (@KobeissiLetter) <a href="https://twitter.com/KobeissiLetter/status/1912204673240662143?ref_src=twsrc%5Etfw">April 15, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Apart from this, the World Gold Council data for the first quarter released last week highlighted that Gold ETFs saw an inflow of 226.5 metric tons worth $21.1 billion, the largest amount since the first quarter of 2022.
Following this, Gold ETF holdings increased by 3% to 3,445.3 tons by March-end, the highest since May 2023 but below the record 3,915 tons in October 2020. However, the World Gold Council noted that U.S.-listed funds saw the largest inflow in the first quarter with 133.8 tons, followed by Europe-listed funds with 54.8 tons.
All Gold-linked ETFs have risen over 21% year-to-date in 2025.
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Gold ETFs</td>
<td>YTD Performance</td>
<td>One Year Performance</td>
</tr>
<tr>
<td>Franklin Responsibly Sourced Gold ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FGDL#NYSE">FGDL</a>)</td>
<td>21.75%</td>
<td>35.37%</td>
</tr>
<tr>
<td>Goldman Sachs Physical Gold ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/AAAU#BATS">AAAU</a>)</td>
<td>21.41%</td>
<td>34.91%</td>
</tr>
<tr>
<td>GraniteShares Gold Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAR#NYSE">BAR</a>)</td>
<td>21.46%</td>
<td>34.99%</td>
</tr>
<tr>
<td>VanEck Merk Gold ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OUNZ#NYSE">OUNZ</a>)</td>
<td>21.31%</td>
<td>34.75%</td>
</tr>
<tr>
<td>SPDR Gold Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLD#NYSE">GLD</a>)</td>
<td>21.33%</td>
<td>34.61%</td>
</tr>
<tr>
<td>iShares Gold Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IAU#NYSE">IAU</a>)</td>
<td>21.42%</td>
<td>34.88%</td>
</tr>
<tr>
<td>SPDR Gold MiniShares Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLDM#NYSE">GLDM</a>)</td>
<td>21.47%</td>
<td>35.05%</td>
</tr>
<tr>
<td>abrdn Physical Gold Shares ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SGOL#NYSE">SGOL</a>)</td>
<td>21.43%</td>
<td>34.92%</td>
</tr>
<tr>
<td>iShares Gold Trust Micro (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IAUM#NYSE">IAUM</a>)</td>
<td>21.49%</td>
<td>35.04%</td>
</tr>
<tr>
<td>Invesco DB Precious Metals Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DBP#NYSE">DBP</a>)</td>
<td>17.90%</td>
<td>24.48%</td>
</tr>
</tbody>
</table>
</figure>
See Also: <a href="https://www.benzinga.com/markets/25/04/44831287/trump-administration-imposes-up-to-245-tariff-on-chinese-imports-amid-intensifying-trade-battle">Trump Administration Imposes Up To 245% Tariff On Chinese Imports Amid Intensifying Trade Battle</a>
Why It Matters: When compared with data from over 25 years, gold prices have skyrocketed 1046.5% from $288.25 on Dec. 31, 1999, to $3,304.80 today. In comparison, the S&amp;P 500 index has risen by 267.31% from 1,469.25 on Dec. 31, 1999, to 5,396.63 as of Tuesday&#8217;s close.
According to Zafar Shaikh, the founder &amp; CEO of Invesys Capital, gold prices have doubled over the last 30 months. This last happened in 2008 and 2011. However, he cautioned that &#8220;So it may still have some juice left but if you are late to the GOLD party, take a deep breath &amp; let it pass rather than getting attracted by $5000 targets.&#8221;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">30 months since <a href="https://twitter.com/hashtag/GOLD?src=hash&amp;ref_src=twsrc%5Etfw">#GOLD</a> started bullrun in 2022 &amp; it&#39;s up 100% Other times when GOLD doubled in 30M was in 2008 &amp; 2011 which was followed by major correction or top for gold So it may still have some juice left but if you are late to the GOLD party, take a deep breath &amp; let it… <a href="https://t.co/glE8ikwflx">pic.twitter.com/glE8ikwflx</a>
&mdash; Zafar Shaikh (@InvesysCapital) <a href="https://twitter.com/InvesysCapital/status/1912436389808906283?ref_src=twsrc%5Etfw">April 16, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Meanwhile, Christopher Aaron, the founder of iGold Advisor, highlighted the Dow-to-Gold ratio in a chart, which showed that the ratio had broken a 45-year best-fit trend. The chart said that this pattern suggested that gold could outpace general equities over the next several decades.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">No one is paying attention to this chart &#8212; and it is the single most important chart in all of finance&#8230;<a href="https://twitter.com/hashtag/gold?src=hash&amp;ref_src=twsrc%5Etfw">#gold</a> <a href="https://t.co/MQnJgUT5mp">pic.twitter.com/MQnJgUT5mp</a>
&mdash; Christopher Aaron (@iGlobalGold) <a href="https://twitter.com/iGlobalGold/status/1912289374584328695?ref_src=twsrc%5Etfw">April 15, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Economist Peter Schiff, on the other hand, spoke about gold mining stocks and said in a X post that &#8220;The time to invest in gold mining stocks is now before the market surges again!&#8221;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Gold&#39;s explosive rally from $2,000 to $3,000 caught investors off guard, and now it&#39;s aiming for $3,500. With China's economic grip tightening, is the US prepared for a shift in the global balance? The time to invest in gold mining stocks is now before the market surges again!… <a href="https://t.co/eys6gXzJYV">pic.twitter.com/eys6gXzJYV</a>
&mdash; Peter Schiff (@PeterSchiff) <a href="https://twitter.com/PeterSchiff/status/1912429831582626183?ref_src=twsrc%5Etfw">April 16, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Price Action: Gold was trading at $3,304.80, whereas the ETF tracking the S&amp;P 500 index, SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>), was down 0.73% in premarket.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/04/44832789/sp-500-typically-gains-18-in-a-year-after-vix-drops-from-50-to-30-level-heres-what-analysts-say">S&amp;P 500 Typically Gains 18% In A Year After VIX Drops From 50 To 30 Level: Here&#8217;s What Analysts Say</a></li>
</ul>
Image Via Shutterstock

Analyst Color

Sector ETFs

Economics

ETFs

General

AAAU

FGDL

GLDM

IAUM

OUNZ

SGOL

Gold Fund Inflows Smash Record With $80 Billion In 2025 — These ETFs Are Riding The $3,300 Surge

RIME

Algorhythm Holdings  2024 Revenue $23.5M vs $29.2M YoY; EPS $(353.87) vs $(263.04) YoY

Gorilla Technology Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRRR#NASDAQ">GRRR</a>) ("Gorilla" or the "Company"), today filed suit against Culper Research ("Culper") and its founder, Christian Lamarco, for making false, misleading and defamatory statements in its short report on the Company dated 4 April 2025. Gorilla is seeking compensatory and punitive damages from Culper and Mr. Lamarco. The Company today issued the following statement:
Gorilla Technology has always operated to the highest standards of integrity and professionalism. We will not tolerate false statements that harm our business or mislead our stakeholders. This legal action is a firm statement of our commitment to defend the truth, protect our reputation and ensure that bad actors are held accountable.
Culper's false and misleading statements have caused significant harm to Gorilla, including artificially depressing the price of Gorilla's stock and damaging Gorilla's reputation. The report made baseless and malicious accusations regarding Gorilla's business, products and strategic partners, in what appears to be a coordinated attempt to mislead the public and manipulate Gorilla's share price-all for its own profit.
Culper's report goes beyond any market distortion or disinformation efforts we have observed; it was especially brazen and nefarious. By filing this lawsuit, we are making it clear that Gorilla will not remain silent in the face of defamatory attacks, and we will vigorously defend the credibility of our products, our people and our partners.

Short Sellers

Legal

GRRR

Gorilla Technology Sues Culper Research And Founder Christian Lamarco For Defamation, Alleging False And Malicious Short Report Aimed At Manipulating Stock Price, Damaging Reputation, And Misleading Investors

B of A Securities analyst Vivek Arya maintains NVIDIA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) with a Buy and lowers the price target from $200 to $160.

NVDA

B of A Securities Maintains Buy on NVIDIA, Lowers Price Target to $160

Entertainment

Press Releases

Cineverse Partners with SymphonyAI to Accelerate AI Capabilities of Matchpoint Insights Platform

Cineverse Hires Industry Veterans Laura Schumer and Ben Cabonargi to Lead Direct Ad Sales for Rapidly Growing Podcast Network

Cineverse Partners with The Trade Desk to Optimize Programmatic Ad Inventory through OpenPath

Cineverse Celebrates Half Way to Halloween With Slate of Harrowing Films including ART ATTACK!, the Behind The Scenes Look at Terrifier 3

Cineverse Chooses Iconic Events Releasing as Distribution Partner for the Theatrical Return of Comedy Horror Franchise The Toxic Avenger

Cineverse Hires Tim Russell, Promotes Terry City as Direct Advertising Sales Team Expands

Cineverse's RetroCrush Acquires Exclusive Streaming Rights to Classic Sci-Fi Anime Series "Future Boy Conan" from GKIDS

Cineverse Expands Existing Line of Credit Facility with East West Bank to $15 Million with a Three-Year Term

Cineverse Acquires U.S. Rights to Lynchian Thriller The Things You Kill; Fall Theatrical Release Planned

Cineverse Launches "Land of the Lost" and "So…Real" FAST Channels on Philo

CNVS

AMC Entertainment Holdings, Inc. Class A Common Stock

AMC Entertainment Hldgs

Anghami

Brera Holdings PLC - Class B Ordinary Shares

Brera Holdings

Pop Culture Group Co., Ltd - Class A Ordinary Shares

Pop Culture Gr

CuriosityStream Inc. - Class A Common Stock

CuriosityStream

Dolphin Entertainment, Inc. - Common Stock

Dolphin Entertainment

Eventbrite

Gaia

Global Mofy AI Limited - Class A Ordinary Shares

Global Mofy AI

Kuke Music Holding Limited American Depositary Shares (each representing ten (10) Class A Ordinary Shares)

Comments

Cineverse

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO